BioIndustry Association - 2021 Review - A game of two halves
January 2022
The UK listed biotech sector ended 2021 ahead of the broader UK market benchmark, marking a second consecutive year of outperformance. Inevitably, the extraordinary outperformance delivered in 2020 was unlikely to be surpassed, or even matched, but 2021 marked a further year of progress.
Download